Entering text into the input field will update the search result below

Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow

SA Transcripts profile picture
SA Transcripts

The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with this event.

Teva Pharmaceutical Industries Ltd.

This article was written by

SA Transcripts profile picture
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Recommended For You

Comments (7)

Net debt < 3x EBITDA ?
This is fantasy unless Teva are going to see up large parts of the business.

How do they propose to pay down between 6- 8 billion in debt in the next two years ?

Or is there some wonder product they're going to launch to suddenly grow sales between now and the end of 2023 ?
@CM Burns obviously you need help to do the math - end of 2023 are 3 years - assuming FCF of 2 billion a year this is debt reduction by 6 billion. 4th grade math.
@CM Burns @IQ-Investment
Not to mention that Kare has been delivering on this plan since he's announced it. Their debt pay-down run rate is on track to do exactly what he said he would do.
@the_man_with_the_golden_berg Their debt pay down has largely relied on refinancing and kicking the can down the road anyone who invests in this company needs their head reading.
05 Mar. 2021
High Yiled, huh? May want to try again with the title...
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.